WHO Health Emergencies Programme

WHO Health Emergencies Programme
Name	WHO Health Emergencies Programme
Formation	2016
Type	Health emergency management
Headquarters	Geneva, Switzerland
Parent organization	World Health Organization
Leader title	Director
Website	www.who.int

Contents

WHO Health Emergencies Programme

The WHO Health Emergencies Programme is a specialized program within the World Health Organization established to coordinate international public health responses to epidemics, pandemics, natural disasters, and humanitarian crises. It operates from Geneva and interacts with agencies such as the United Nations, World Bank, Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control, and regional health authorities to manage outbreaks including Ebola virus disease, Zika virus, and COVID-19 pandemic. The programme builds on experiences from the 2014 Ebola epidemic in West Africa, lessons from the H1N1 pandemic, and mandates arising from the International Health Regulations (2005) and global health security frameworks.

History and Establishment

The programme was created following high-level reviews that involved actors like the United Nations Secretary-General, the Global Health Security Agenda, and the Commission on a Global Health Risk Framework for the Future after the 2014 Ebola epidemic in West Africa. Influential reports by the Harvard Global Health Institute, the Independent Panel on Pandemic Response, and consultations with the G7 and G20 informed the restructuring that led to the programme's inauguration in 2016 by the World Health Assembly and senior officials from the World Health Organization. Founding directors referenced operational models from institutions such as Médecins Sans Frontières, the International Committee of the Red Cross, and the United Nations Office for the Coordination of Humanitarian Affairs.

The programme's mandate aligns with instruments like the International Health Regulations (2005), resolutions passed by the World Health Assembly, and strategic guidance from bodies such as the United Nations General Assembly and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Objectives include rapid detection and response to threats exemplified by SARS, MERS-CoV, and Avian influenza, strengthening country capacity analogous to frameworks from the Joint External Evaluation process, and supporting preparedness activities referenced by the Sendai Framework for Disaster Risk Reduction and the Pandemic Influenza Preparedness Framework. It also coordinates laboratory networks including connections to the Pasteur Institute, U.S. National Institutes of Health, and regional public health laboratories.

Governance of the programme is overseen by the World Health Organization executive management and reports to the World Health Assembly and the Executive Board of WHO. Its internal structure includes regional emergency hubs similar to models used by the Pan American Health Organization, the African Union, and the European Commission. Leadership draws on experts from institutions such as the London School of Hygiene & Tropical Medicine, the Johns Hopkins Bloomberg School of Public Health, and the Liverpool School of Tropical Medicine. Advisory inputs have come from panels including the Independent Oversight and Advisory Committee, the Global Health Cluster, and the World Bank Pandemic Emergency Financing Facility governance mechanisms.

Operational activities encompass outbreak investigation, clinical management guidance, and health system surge support during crises like the 2014 Ebola epidemic in West Africa, the 2015–16 Zika virus epidemic, and the COVID-19 pandemic. The programme deploys emergency medical teams modeled after standards from the World Health Assembly and partners with NGOs including Médecins Sans Frontières, Save the Children, and International Rescue Committee for field operations in settings such as Sierra Leone, Liberia, Guinea, and Yemen. It coordinates surveillance with networks like ProMED-mail, laboratory confirmation with the Pasteur Institute, and supplies provision through mechanisms used by the Global Fund to Fight AIDS, Tuberculosis and Malaria and the United Nations Office for Project Services.

Financing combines assessed contributions channeled through the World Health Organization and voluntary contributions from states and donors including the United States Agency for International Development, the United Kingdom Department for International Development, philanthropic partners such as the Bill & Melinda Gates Foundation, and multilateral lenders like the World Bank. Public–private collaborations involve entities such as Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and pharmaceutical firms that coordinate under frameworks exemplified by the International Health Regulations (2005). Partnerships extend to regional bodies like the African Union and technical cooperation with research institutes such as the Wellcome Trust and the Rockefeller Foundation.

The programme has faced scrutiny in independent evaluations by panels including the Independent Oversight and Advisory Committee and the Independent Panel for Pandemic Preparedness and Response, particularly over responses to the 2014 Ebola epidemic in West Africa and early stages of the COVID-19 pandemic. Critiques invoked reviews from the World Health Assembly, analyses by the London School of Hygiene & Tropical Medicine, and reports from the Harvard Global Health Institute calling for reforms in funding, transparency, and incident management systems exemplified by reforms recommended after the H1N1 pandemic. Reforms implemented drew on models from the International Health Regulations (2005), the Global Health Security Agenda, and governance changes endorsed by the Executive Board of WHO and member states, while ongoing debates involve stakeholders such as the G7, G20, and civil society organizations including Médecins Sans Frontières and the Red Cross and Red Crescent Movement.

Category:World Health Organization programs